Pharma tariff bombshell: Navigating challenges, building resilience
Chakravarthi AVPS, International Trade & Business Relations Expert in pharmaceuticals, opines that for India Pharma Inc, the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pharma tariffs
Trump imposes 100 per cent tariff on patented drugs; impact on India to be limited
Industry experts weigh in on the latest tariff move. They highlight limited near-term disruption but caution about long-term risks…
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a…
Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
CDSCO issues compliance framework for SEZ-to-DTA drug transfers
New circular standardises licensing pathway for domestic diversion of SEZ-manufactured drugs; however system-level changes raise…
US eyes pharma tariffs in next trade wave
Indian pharma exports escape current round of US reciprocal tariffs, but White House signals upcoming policy shift with possible…